HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Trauzold Selected Research

TNF-Related Apoptosis-Inducing Ligand

6/2021Topology impacts TRAIL therapy: Differences in primary cancer growth and liver metastasis between orthotopic and subcutaneous xenotransplants of pancreatic ductal adenocarcinoma cells.
1/2021TRAIL-receptor 2-a novel negative regulator of p53.
3/2019TRAILblazing Strategies for Cancer Treatment.
1/2019Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients.
1/2019TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
1/2019Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
3/2018Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.
2/2013TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells.
4/2008The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Trauzold Research Topics

Disease

32Neoplasms (Cancer)
01/2022 - 04/2005
13Adenocarcinoma
06/2021 - 12/2003
10Neoplasm Metastasis (Metastasis)
06/2021 - 03/2008
9Pancreatic Neoplasms (Pancreatic Cancer)
10/2018 - 04/2005
4Breast Neoplasms (Breast Cancer)
01/2020 - 04/2015
2Carcinoma (Carcinomatosis)
01/2019 - 04/2015
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2021
1Triple Negative Breast Neoplasms
06/2020
1Pancreatic Ductal Carcinoma
05/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
06/2018
1Circulating Neoplastic Cells
06/2018
1Leprosy (Hansen's Disease)
06/2017
1Autoimmune Diseases (Autoimmune Disease)
06/2017
1Bone Diseases (Bone Disease)
03/2017
1Necrosis
02/2014
1Carcinogenesis
01/2012
1Peritoneal Neoplasms
06/2011

Drug/Important Bio-Agent (IBA)

10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 03/2008
9LigandsIBA
01/2022 - 04/2008
9TNF-Related Apoptosis-Inducing LigandIBA
06/2021 - 04/2008
7TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021 - 02/2013
7Death Domain ReceptorsIBA
05/2019 - 04/2005
6Proteins (Proteins, Gene)FDA Link
05/2019 - 01/2012
5AntibodiesIBA
06/2021 - 07/2010
4Phosphotransferases (Kinase)IBA
01/2020 - 12/2003
4Pharmaceutical PreparationsIBA
01/2019 - 06/2011
4Interleukin-8 (Interleukin 8)IBA
02/2013 - 04/2008
3CytokinesIBA
02/2014 - 03/2008
2MicroRNAs (MicroRNA)IBA
01/2021 - 01/2014
2lexatumumabIBA
01/2019 - 07/2010
2mapatumumabIBA
01/2019 - 07/2010
2Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2018
2TNF Receptor-Associated Factor 2 (TRAF2)IBA
02/2013 - 04/2005
2Infliximab (Remicade)FDA Link
06/2011 - 03/2008
2NF-kappa B (NF-kB)IBA
07/2010 - 04/2008
1Tumor Suppressor Protein p53IBA
01/2021
1Phenobarbital (Luminal)FDA Link
06/2020
1Dasatinib (BMS 354825)FDA Link
01/2020
1Tyrosine (L-Tyrosine)FDA Link
01/2020
1CSK Tyrosine-Protein KinaseIBA
01/2020
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2019
1PerforinIBA
01/2019
1Granzymes (Granzyme)IBA
01/2019
1argatroban (MPQA)FDA Link
01/2019
1Hyaluronic Acid (Hyaluronan)IBA
01/2019
1Keratin-20 (Cytokeratin 20)IBA
06/2018
1navitoclaxIBA
01/2018
1APG350IBA
01/2018
1Clofazimine (Lamprene)FDA Link
06/2017
1AntimetabolitesIBA
03/2017
15-fluoro-2'-deoxyuridineIBA
03/2017
1Alendronate (Alendronate Sodium)FDA LinkGeneric
03/2017
1Diphosphonates (Bisphosphonates)IBA
03/2017
15-FdU-alendronateIBA
03/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2016
1CarcinogensIBA
11/2016
1ChemokinesIBA
04/2015
1Mitochondrial Proteins (Mitochondrial Protein)IBA
04/2015
1OvalbuminIBA
04/2015
1GemcitabineFDA Link
04/2015
1AntigensIBA
04/2015
1Cancer VaccinesIBA
04/2015
1Small Interfering RNA (siRNA)IBA
04/2015
1CeramidesIBA
02/2014
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2013
1Tumor Viral Antigens (Large T Antigen)IBA
01/2012
1Cytostatic AgentsIBA
06/2011
1epicatechin gallateIBA
04/2011
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
04/2011
1TeaIBA
04/2011
1catechin gallateIBA
04/2011
1GlucocorticoidsIBA
07/2008
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2008
1CaspasesIBA
04/2008
1Etanercept (Enbrel)FDA Link
03/2008
1Histone Deacetylases (Histone Deacetylase)IBA
11/2006
1Histone Deacetylase InhibitorsIBA
11/2006
1protein kinase DIBA
12/2003

Therapy/Procedure

11Therapeutics
06/2021 - 11/2006
2Heterologous Transplantation (Xenotransplantation)
01/2018 - 06/2017
1Palliative Care (Palliative Therapy)
01/2018
1Chemoprevention
03/2017
1Pancreatectomy
03/2008